Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group
Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group
复制标题
DOI:
10.1007/s12185-010-0754-y
复制
发表时间:
2011-01-01
影响因子:
2.1
通讯作者:
Komada, Yoshihiro
中科院分区:
文献类型:
--
作者:
Ohta, Hideaki;Iwamoto, Shotaro;Komada, Yoshihiro
M0 (acute myeloid leukemia without differentiation, n= 11), M1 (acute myelocytic leukemia with little differentiation, n= 41), M2 (acute myelocytic leukemia with differentiation, n= 113), M4 (acute myelomonocytic leukemia, n= 47), M5 (acute monocytic leukemia, n= 54), M6 (acute erythroleukemia, n= 6), and M7 (acute megakaryoblastic leukemia, n= 61). Mononuclear cells of bone marrow or peripheral blood samples were stained with various combinations of fluorescein isothiocyanate (FITC)-and phycoerythrin (PE)-labeled monoclonal antibodies against the following antigens: CD4, CD7, CD13, CD14, CD15, CD19, CD33, CD34, CD36, CD41, CD42b, CD45, CD56, CD61, CD65, CD117, glycophorin A (GPA: CD235a), and HLA-DR. Cytoplasmic MPO was also detected by anti-MPO antibody after permeabilization. Two-color flow cytometric immunophenotyping was performed by collecting 10,000 ungated list mode events. An antigen was considered as